Anaplastic Thyroid Cancer Latest Advances
Find the Latest Research About Anaplastic Thyroid Cancer
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2768 publications
Anaplastic thyroid carcinoma: Importance of early diagnosis and treatment
Journal: Medicina
Published: June 22, 2026
Preparation of all-trans retinoic acid and irinotecan co-loaded liposomes and their in vitro evaluation against anaplastic thyroid cancer
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: June 15, 2026
Inhibitory effect of lonafarnib on anaplastic thyroid carcinoma cell lines and a nude mouse xenograft model
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: June 08, 2026
Enhanced Therapeutic Efficacy of Combined Photothermal Therapy and Doxorubicin Chemotherapy in Anaplastic Thyroid Carcinoma: An Innovative Treatment Approach.
Journal: Molecular pharmaceutics
Published: June 04, 2026
Mechanism of timosaponin AⅢ liposomes loaded with auranofin in inducing ferroptosis in anaplastic thyroid carcinoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: May 18, 2026
Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients.
Journal: Endocrine journal
Published: May 13, 2026
Correction: RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex.
Journal: Cell & bioscience
Published: April 29, 2026
Durable response of anaplastic thyroid cancer to pembrolizumab combined with chemotherapy: A case report.
Journal: Human vaccines & immunotherapeutics
Published: April 16, 2026
CGE26-134: Sex-Associated 1q Signatures in Anaplastic Thyroid Cancer: TCGA and Cell-Line Validation.
CGE26-134: Sex-Associated 1q Signatures in Anaplastic Thyroid Cancer: TCGA and Cell-Line Validation.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Dendrobine inhibits anaplastic thyroid cancer progression by targeting the JAK-STAT3 pathway.
Journal: Frontiers in oncology
Published: March 30, 2026
Last Updated: 06/30/2026